These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies. Birdsall NJ, Farries T, Gharagozloo P, Kobayashi S, Lazareno S, Sugimoto M. Mol Pharmacol; 1999 Apr; 55(4):778-86. PubMed ID: 10101037 [Abstract] [Full Text] [Related]
3. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors. Lazareno S, Birdsall NJ. Mol Pharmacol; 1995 Aug; 48(2):362-78. PubMed ID: 7651370 [Abstract] [Full Text] [Related]
4. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies. Lazareno S, Gharagozloo P, Kuonen D, Popham A, Birdsall NJ. Mol Pharmacol; 1998 Mar; 53(3):573-89. PubMed ID: 9495826 [Abstract] [Full Text] [Related]
5. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. Jakubík J, Bacáková L, el-Fakahany EE, Tucek S. J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472 [Abstract] [Full Text] [Related]
6. Allosteric effects of four stereoisomers of a fused indole ring system with 3H-N-methylscopolamine and acetylcholine at M1-M4 muscarinic receptors. Lazareno S, Birdsall B, Fukazawa T, Gharagozloo P, Hashimoto T, Kuwano H, Popham A, Sugimoto M, Birdsall NJ. Life Sci; 1999 Sep; 64(6-7):519-26. PubMed ID: 10069518 [Abstract] [Full Text] [Related]
7. The quaternary transformation products of N-(3-chloropropyl)-4-piperidinyl diphenylacetate and N-(2-chloroethyl)-4-piperidinyl diphenylacetate (4-DAMP mustard) have differential affinity for subtypes of the muscarinic receptor. Ehlert FJ, Oliff HS, Griffin MT. J Pharmacol Exp Ther; 1996 Feb; 276(2):405-10. PubMed ID: 8632303 [Abstract] [Full Text] [Related]
8. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Jakubík J, Bacáková L, El-Fakahany EE, Tucek S. Mol Pharmacol; 1997 Jul; 52(1):172-9. PubMed ID: 9224827 [Abstract] [Full Text] [Related]
9. Bisquaternary dimers of strychnine and brucine. A new class of potent enhancers of antagonist binding to muscarinic M2 receptors. Zlotos DP, Buller S, Holzgrabe U, Mohr K. Bioorg Med Chem; 2003 Jun 12; 11(12):2627-34. PubMed ID: 12757728 [Abstract] [Full Text] [Related]
10. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype. Ferrari-Dileo G, Waelbroeck M, Mash DC, Flynn DD. Mol Pharmacol; 1994 Dec 12; 46(6):1028-35. PubMed ID: 7808421 [Abstract] [Full Text] [Related]
11. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. Dörje F, Wess J, Lambrecht G, Tacke R, Mutschler E, Brann MR. J Pharmacol Exp Ther; 1991 Feb 12; 256(2):727-33. PubMed ID: 1994002 [Abstract] [Full Text] [Related]
12. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors. Olianas MC, Ingianni A, Maullu C, Adem A, Karlsson E, Onali P. J Pharmacol Exp Ther; 1999 Jan 12; 288(1):164-70. PubMed ID: 9862767 [Abstract] [Full Text] [Related]
13. Asparagine, valine, and threonine in the third extracellular loop of muscarinic receptor have essential roles in the positive cooperativity of strychnine-like allosteric modulators. Jakubík J, Krejcí A, Dolezal V. J Pharmacol Exp Ther; 2005 May 12; 313(2):688-96. PubMed ID: 15647330 [Abstract] [Full Text] [Related]
14. Allosteric interactions at the m1, m2 and m3 muscarinic receptor subtypes. Lee NH, el-Fakahany EE. J Pharmacol Exp Ther; 1991 Feb 12; 256(2):468-79. PubMed ID: 1993991 [Abstract] [Full Text] [Related]
15. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists. Wang SZ, el-Fakahany EE. J Pharmacol Exp Ther; 1993 Jul 12; 266(1):237-43. PubMed ID: 7687290 [Abstract] [Full Text] [Related]
16. Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes. Birdsall NJ, Farries T, Gharagozloo P, Kobayashi S, Kuonen D, Lazareno S, Popham A, Sugimoto M. Life Sci; 1997 Jul 12; 60(13-14):1047-52. PubMed ID: 9121346 [Abstract] [Full Text] [Related]
17. Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists. Lysíková M, Havlas Z, Tucek S. Neurochem Res; 2001 Apr 12; 26(4):383-94. PubMed ID: 11495349 [Abstract] [Full Text] [Related]
18. Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. Lazareno S, Dolezal V, Popham A, Birdsall NJ. Mol Pharmacol; 2004 Jan 12; 65(1):257-66. PubMed ID: 14722259 [Abstract] [Full Text] [Related]
19. Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters. Lysíková M, Fuksová K, Elbert T, Jakubík J, Tucek S. Br J Pharmacol; 1999 Jul 12; 127(5):1240-6. PubMed ID: 10455271 [Abstract] [Full Text] [Related]